Antihistamines

Verify with FDA CVM →

119 adverse event reports submitted to the FDA

Important: Adverse event reports do not establish that a drug caused or contributed to the event. Consult your veterinarian before making treatment decisions.
119
Total Reports
7
Deaths Reported
590.0%
Death Rate

Active Ingredients

Antihistamines

Administration Routes

UnknownOral

Species Affected

Dog 108
Cat 11

Most Affected Breeds

Retriever - Labrador 13
Terrier - Bull - American Pit 10
Terrier - Yorkshire 8
Bulldog 7
Domestic Shorthair 6
Shepherd Dog - German 5
Terrier (unspecified) 5
Chihuahua 4
Crossbred Canine/dog 4
Bichon Frise 3

Most Reported Reactions

Vomiting 19
Lack of efficacy - NOS 17
INEFFECTIVE, ATOPY CONTROL 12
Diarrhoea 11
Lethargy (see also Central nervous system depression in 'Neurological') 11
Seizure NOS 7
Elevated serum alkaline phosphatase (SAP) 7
Behavioural disorder NOS 6
Other abnormal test result NOS 6
Erythema (for urticaria see Immune SOC) 6
Death by euthanasia 5
Polyuria 5

Outcome Breakdown

Ongoing
82 (68.9%)
Outcome Unknown
21 (17.6%)
Recovered/Normal
9 (7.6%)
Euthanized
5 (4.2%)
Died
2 (1.7%)

Data Summary

Metric Value
Total adverse event reports 119
Reports involving death 7
Case-fatality rate (reported events) 590.0%
Distinct species in reports 2
Distinct breeds in reports 20
Distinct reactions reported 20
Active ingredients on file 1

Source: FDA Center for Veterinary Medicine — Adverse Event Reporting (CVM AER). Counts reflect voluntary reports only.

Antihistamines Adverse Event Insights

The FDA Center for Veterinary Medicine database currently holds 119 adverse event reports referencing Antihistamines, including 7 reports in which the animal died — a 590.0% case-fatality figure among reported events only, not a population-level mortality rate. Active ingredient on file: Antihistamines. Reported administration routes include Unknown, Oral. These numbers reflect voluntary submissions from pet owners, veterinarians, and manufacturers and therefore under-represent mild events and over-represent severe ones — a pattern the FDA has documented repeatedly for pharmacovigilance datasets.

The species most frequently named in Antihistamines reports are Dog (108 reports), Cat (11 reports), with Dog accounting for the largest share. Within those species, Retriever - Labrador (13), Terrier - Bull - American Pit (10), Terrier - Yorkshire (8) appear most often — though breed popularity and ownership density shape these counts as much as any drug-specific sensitivity. This distribution matters because the same active ingredient can behave very differently across body sizes, ages, and species physiology.

The most commonly reported clinical signs associated with Antihistamines are Vomiting (19), Lack of efficacy - NOS (17), INEFFECTIVE, ATOPY CONTROL (12), Diarrhoea (11). Of the 119 reports with a coded outcome, Ongoing is the leading category at 68.9%. Because FDA adverse event data describes correlation rather than causation, these figures are best used to frame informed questions with a veterinarian and to compare reporting patterns across related products — not as a standalone safety verdict on Antihistamines.

Source: FDA Center for Veterinary Medicine — Adverse Event Reports FDA Center for Veterinary Medicine — Adverse Event Reports Data reflects voluntary submissions and may not represent actual incidence rates

Related

Data sourced from official AKC, AVMA, ACVO, and breed-club veterinary references. See our methodology for details. Retrieved and formatted by PlainBreed Editorial